Go to patient/caregiver site Go to healthcare provider site WATCH THIS AUVI-Q STORY

AUVI-Q was designed to be easy to carry and easy to use for whoever may be called upon to use it. It features:

  • Voice Instructions
  • pocket-sized
  • auto-retractable needle

Watch our friend Ben simulate the 3-step injection process.6

Seek emergency medical help immediately after use.

  • If voice instructions do not work for any reason, AUVI-Q will still work during an allergic emergency.
  • Always read the full Instructions for Use found in the Patient Information.
do you prefer to read the instructions?

Infants and toddlers (weighing 16.5 lbs to 33 lbs) with life-threatening allergies may be prescribed AUVI-q® (epinephrine injection, USP) 0.1 mg. Skip down to more information about AUVI-q 0.1 mg to watch a different administration video for the 0.1 mg strength.

Who might have to administer auvi-q?

Allergic emergencies can occur outside the home, and people with little or no training may be called upon to administer epinephrine, including1-5,7,8:

What if someone with little or no training is asked to use AUVI-Q?

were able to complete a simulated injection with AUVI-Q on the first try.9

In one study, 100% of adults aged 16-55 years (n=20) and 95% of pediatric patients aged 7-15 years (n=20) were able to complete a simulated injection with AUVI-Q on their first try without making a critical use error or getting any training from a healthcare practitioner.9

Voice instructions help guide users through an injection, step by step

AUVI-Q features an electronic voice-instruction system—you can hear for yourself what it sounds like.6

What to expect

A 2-second countdown begins after AUVI-Q is activated. Voice instructions will indicate the injection is complete, AUVI-Q will beep, and the lights will blink red. After use, seek immediate medical attention.6

Listen to Shannon—the mother of a child with a life-threatening allergy—
as she explains what voice instructions of AUVI-Q mean to her.

Head over to information about how you can have your Amazon Alexa voice assistant play the AUVI-Q recording on command.

designed with size in mind

About the size of a credit card and thickness of a cell phone, AUVI-Q fits in most pockets.

Asset 2

Does it fit? Let’s try it:

Both the size and shape of AUVI-Q are preferred over EpiPen® (epinephrine injection, USP)10

In a study where 693 people (ages 11-65) were asked about their preferences, AUVI-Q was significantly (P<0.001) preferred over EpiPen in 2 key measures10:

AUVI-Q is the first and only epinephrine auto‑injector with an auto-retractable needle

Only with AUVI-Q:

  • The needle comes out of the device to deliver epinephrine, and then automatically pulls back in to the device when the injection is complete
  • The needle is not visible before, during, or after an injection
  • Users may not feel the injection when it happens6

With the auto-retractable needle, epinephrine delivery is complete in less than half a second. However, users must push firmly and hold for a complete 2-second count.6

You can see a real-time simulation of AUVI-Q being used here, or a different simulation of the AUVI-q 0.1 mg strength here.

If you inject a young child or infant with AUVI-Q, hold their leg firmly in place before and during the injection to prevent injuries. Ask your doctor or nurse to show you how to properly hold the leg of a young child or infant during injection.6

Beyond an auto-retractable needle, the AUVI-q 0.1 mg needle has other features specifically designed for infants and toddlers weighing 16.5 lbs to 33 lbs with life-threatening allergies. Keep reading for more.

meet the auvi-q family

Ask your doctor which of the 3 strengths available is right for you or your child.

AUVI-q 0.1 mgFor infants and toddlers weighing 16.5 lbs to 33 lbs.

AUVI-Q 0.15 mgFor children weighing 33 lbs to 66 lbs.

AUVI-Q 0.3 mgFor anyone who weighs 66 lbs or more.

AUVI-q 0.1 mgFor infants and toddlers weighing 16.5 lbs to 33 lbs.

AUVI-Q 0.15 mgFor children weighing 33 lbs to 66 lbs.

AUVI-Q 0.3 mgFor anyone who weighs 66 lbs or more.

AUVI-q 0.1 mg is the first and only FDA-approved epinephrine auto-injector designed specifically for infants and toddlers weighing 16.5 lbs to 33 lbs.

The shortest available needle among epinephrine
auto-injectors that helps deliver the dose at the right depth.

Though users must press and hold for 2 seconds,
the injection is completed in less than a second.

AUVI-q 0.1 mg contains the same easy-to-use features as the rest of the product family.

Take a look at a simulated injection with the AUVI-q 0.1 mg dose.

If you inject a young child or infant with AUVI-q, hold their leg firmly in place before and during the injection to prevent injuries.6 Ask your healthcare provider to show you how to properly hold the leg of a young child or infant during an injection.

Compare this video with one showing how a teen or adult can self-administer their AUVI-Q to see how the features were designed to make all AUVI-Q devices easy to use.

Developed by Patients, for Patients®

Our story starts with twin brothers who grew up with life-threatening allergies, became an engineer and a doctor, and invented AUVI-Q. Now, the AUVI-Q community spans the country.

This is Valerie.

2 kids—multiple allergies

Home state: Nevada

Family members with LTA: son Cole, daughter Taylor

First anaphylactic attack: (Cole) sesame treat, age 14 months, on vacation

Allergen(s): (Cole) sesame, tree nuts; (Taylor) milk, eggs, peanuts, legumes

First prescribed AUVI-Q in: 2014

“What I like best about the AUVI-Q was that it was very slim, and so it could fit easily in pockets and in my purse, but I also really like the features of its audible instructions.”

This is Shannon.

Used AUVI-Q in a van

Home state: Virginia

Family members with LTA: son Brendan

First anaphylactic attack: unknown, age 9, at the breakfast table

Allergen(s): unknown

First prescribed AUVI-Q in: 2015

“There were a number of things that really appealed to us about AUVI-Q, right out of the gate. The first was the size and the shape of the unit.”

This is Daniella.

Flight attendant/allergy mom

Home state: Idaho

Family members with LTA: son Sam

First anaphylactic attack: peanut butter sandwich, age 2, at daycare

Allergen(s): Peanuts, tree nuts, dairy, eggs, soy, avocado, kiwi

First prescribed AUVI-Q in: 2014

“My son is absolutely thrilled to be able to carry that AUVI-Q—to be able to put it in his pocket—and he carries it without having to be told to do it.”

Ready to become a part of the AUVI-Q Community?

Find out more about how to get AUVI-Q.

get auvi-q

All eligible commercially insured patients can get AUVI-Q for $0 out of pocket.*

If you have commercial insurance and are eligible—even if your plan has a high deductible—you pay $0 out of pocket.*

*Please see full terms and conditions.

Getting Auvi-q has never been easier

If you and your doctor determine AUVI-Q is right for you, you can choose to either:

HAVE YOUR PRESCRIPTION SENT TO WALGREENS FOR IN-STORE PICKUP

Use this store finder to see the locations near you:

OR

USE THE DIRECT DELIVERY SERVICE to have AUVI-Q shipped to your door.
Get the details here.

Questions? Ask a real person. 1-877-30-AUVIQ

WHAT IS IN EACH BOX OF AUVI-Q?

Each prescription pack will contain 2 auto-injectors and 1 Trainer

The Trainer for AUVI-Q does not contain a needle or medicine and can be reused to practice an injection.

It is important to practice with the Trainer for AUVI-Q before an allergic emergency happens to ensure you are able to safely use the real AUVI-Q in an emergency.

auvi-q expiration date reminder

Sign up now, thank yourself later

Sign up to get an email reminder 30 days before the expiration date so you can work with your doctor to make sure your prescription is always up to date.

GET A REMINDER

kaléo Cares Patient Assistance Program

Through the kaléo Cares Patient Assistance Program, patients who do not have commercial insurance and who are experiencing financial difficulties may be able to receive AUVI-Q at no cost.*

LEARN MORE

To be eligible for assistance, you must:

  • Have a prescription for AUVI-Q.
  • Be a legal US resident.
  • Not have any government or commercial drug coverage.
  • Have an annual household income of less than $100,000.

*Patients who are eligible for Medicaid coverage may be eligible for assistance to receive AUVI-Q at no cost.

If you have any questions or concerns about your shipment of AUVI-Q, give us a call at 1-877-30-AUVIQ

Is your school ready to respond to an allergic emergency?

If you’re a school nurse or administrator, getting AUVI-Q into your school is simple.

GET STARTED

Already have AUVI-Q in your school?

Download a School Nurse Kit to help raise awareness of life-threatening allergies

Keep the learning going

Get to the right resources fast. Choose the filters that best fit the information on life-threatening allergies (LTAs) that you are looking for.

Indication
AUVI-Q® (epinephrine injection, USP) is a prescription medicine used to treat life-threatening allergic reactions, including anaphylaxis, in people who are at risk for or have a history of serious allergic reactions.

Important Safety Information

AUVI-Q is for immediate self (or caregiver) administration and does not take the place of emergency medical care. Seek immediate medical treatment after using AUVI-Q. Each AUVI-Q contains a single dose of epinephrine. AUVI-Q should only be injected into your outer thigh, through clothing if necessary. If you inject a young child or infant with AUVI-Q, hold their leg firmly in place before and during the injection to prevent injuries. Do not inject AUVI-Q into any other part of your body, such as into veins, buttocks, fingers, toes, hands, or feet. If this occurs, seek immediate medical treatment and make sure to inform the healthcare provider of the location of the accidental injection. Only a healthcare provider should give additional doses of epinephrine if more than two doses are necessary for a single allergic emergency.

Rarely, patients who use AUVI-Q may develop infections at the injection site within a few days of an injection. Some of these infections can be serious. Call your healthcare provider right away if you have any of the following symptoms at an injection site: redness that does not go away, swelling, tenderness, or the area feels warm to the touch.

If you have certain medical conditions, or take certain medicines, your condition may get worse or you may have more or longer lasting side effects when you use AUVI-Q. Be sure to tell your healthcare provider about all the medicines you take, especially medicines for asthma. Also tell your healthcare provider about all of your medical conditions, especially if you have asthma, a history of depression, thyroid problems, Parkinson’s disease, diabetes, heart problems or high blood pressure, have any other medical conditions, are pregnant or plan to become pregnant, or are breastfeeding or plan to breastfeed. Epinephrine should be used with caution if you have heart disease or are taking certain medicines that can cause heart-related (cardiac) symptoms.

Common side effects include fast, irregular or ‘pounding’ heartbeat, sweating, shakiness, headache, paleness, feelings of over excitement, nervousness, or anxiety, weakness, dizziness, nausea and vomiting, or breathing problems. These side effects usually go away quickly, especially if you rest. Tell your healthcare provider if you have any side effect that bothers you or that does not go away.

Please see the full Prescribing Information and the Patient Information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

References

  1. Tiyyagura GK, Arnold L, Cone DC, Langhan M. Pediatric anaphylaxis management in the prehospital setting. Author manuscript published by the National Institutes of Health, Public Access, PMC January 1, 2015;1-11. Published in final edited form in Prehosp Emerg Care. 2014;18(1):46-51.
  2. Radke TJ, Brown LG, Hoover ER, et al. Food allergy knowledge and attitudes of restaurant managers and staff: an EHS-NET study. Author manuscript published by the Department of Health and Human Services, Public Access, PMC February 23, 2017;1-24. Published in final edited form in J Food Prot. 2016;79(9):1588-1598.
  3. Wahl A, Stephens H, Ruffo M, Jones AL. The evaluation of a food allergy and epinephrine autoinjector training program for personnel who care for children in schools and community settings. J Sch Nurs. 2015;31(2):91-98.
  4. Robinson M, Greenhawt M, Stukus D. Factors associated with epinephrine administration for anaphylaxis in children before arrival to the emergency department. Ann Allergy Asthma Immunol. 2017;119:164-169.
  5. Bock SA, Muñoz-Furlong A, Sampson HA. Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol. 2001;107(1):191-193.
  6. AUVI-Q [prescribing information]. Richmond, VA: kaleo, Inc.; https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=6180fb40-7fca-4602-b3da-ce62b8cd2470&type=display
  7. Allen K, Henselman K, Laird B, Quiñones A, Reutzel T. Potential life-threatening events in schools involving rescue inhalers, epinephrine autoinjectors, and glucagon delivery devices: reports from school nurses. J Sch Nurs. 2012;28(1):47-55.
  8. Young M, Muñoz-Furlong A, Sicherer S. Management of food allergies in schools: a perspective for allergists. J Allergy Clin Immunol. 2009;124(2):175-182.
  9. Edwards ES, Edwards ET, Gunn R, et al. Design validation and labeling comprehension study for a new epinephrine autoinjector. Ann Allergy Asthma Immunol. 2013;110(3):189-193.
  10. Camargo CA Jr, Guana A, Wang S, Simmons FER. Auvi-Q versus EpiPen: preferences of adults, caregivers, and children. J Allergy Clin Immunol Pract. 2013;1(3):266-272.e1-e3.

Terms and Conditions

Only valid for commercially insured patients in the 50 United States and DC through the direct delivery service and/or designated retail pharmacies. Limit one (1) carton of AUVI-q 0.1 mg per patient each calendar year. Limit two (2) cartons of AUVI-Q 0.15 mg or 0.3 mg per patient each calendar year. Individual insurance companies and pharmacies vary and may impose additional requirements that affect the timing and/or redemption of the offer. Not eligible if prescriptions are paid for in part/full by state or federally funded program(s), like Medicare Part D, Medicaid, Vet. Aff., Dept. of Def., or Tricare, and where prohibited by law. OFFER IS NOT INSURANCE. Offer cannot be sold, purchased, traded, transferred, and cannot be combined with any other offer. Cash discount cards are not commercial payers and are not eligible to be used for this program. Offer provided by kaléo, and it may change at any time without notice.

Call 844-357-3968 for questions regarding offer eligibility.

You are leaving www.auvi-q.com

Please understand that AUVI-Q is not responsible for how your information is processed or used on non-AUVI-Q sites. Also note that providing links to non-AUVI-Q sites is not an endorsement of the other site by AUVI-Q or any of its employees. And finally, be aware that the privacy protection provided on our site may not be available on an external link.

EXIT

The health information contained herein is provided for general educational purposes only. Please consult with your healthcare professional if you have any questions about your health or treatment.

Pricing Philosophy for AUVI-Q® (epinephrine injection, USP)

As a company founded by patients with life-threatening allergies, we take our commitment to the needs of patients and their families very seriously. In this era of high deductible health plans, many patients find it harder than ever to afford their medications. We are committed to ensuring thatpatients with commercial insurance, or those facing financial hardship, should be able to obtain our potentially lifesaving products for little to no out-of-pocket cost.

Our Beliefs:
For us, the patient always comes first. We believe the most important price is the price to the patient. We believe that patients with life-threatening conditions deserve fair access to the latest medicines that offer technological innovations that address their medical needs. We believe that when a healthcare practitioner prescribes AUVI-Q, patients should be able to fill their prescription without high out-of-pocket costs.

Our Commitment to Access and Affordability:
We have seen firsthand in this current healthcare system the very real challenges patients are facing in being able to access and afford potentially lifesaving medicines. Similar to our product innovation process, our AUVI-Q patient access program has been built to solve for some of these challenges and help focus on what matters most... access and affordability to AUVI-Q for patients.

Our Commitment to AUVI-Q Manufacturing and Quality:
Kaléo is committed to the highest standards of product and manufacturing quality. Final manufacturing and assembly of AUVI-Q is conducted in the United States on a 100% automated robotic production line with more than 100 automated quality checks on each and every product.

Patients can be confident in our approach to design quality into AUVI-Q and incorporate quality into every aspect of the manufacturing process.

AUVI-Q® (epinephrine injection, USP) administers epinephrine in 3 steps6

STEP 1

Pull AUVI-Q up from the outer case.

Do not go to step 2 until you are ready to use AUVI-Q. If you are not ready to use AUVI-Q, put it back in the outer case.

STEP 2

Pull red safety guard down and off of AUVI-Q.

To reduce the chance of an accidental injection, do not touch the black base of the auto-injector, which is where the needle comes out. If an accidental injection happens, get medical help right away.

Note: The red safety guard is made to fit tightly. Pull firmly to remove.

STEP 3

Place black end of AUVI-Q against the middle of the outer thigh, then push firmly until you hear a click and hiss sound, and hold in place for 2 seconds.

AUVI-Q can inject through clothing if necessary. ONLY inject into the middle of the outer thigh. To minimize the risk of injection-related injury, instruct caregiver to hold a young child’s or infant’s leg firmly in place when administering AUVI-Q.

After use, instruct patient to get emergency help right away.

To minimize the risk of injection-related injury, instruct caregiver to hold a young child’s or infant’s leg firmly in place when administering AUVI-Q.

kaléo Cares Patient Assistance Program

Kaléo, the maker of AUVI-Q, understands the importance of having emergency medications available to patients. We also recognize that some patients may have financial difficulties that prevent them from obtaining these needed medications.

Through the kaléo Cares Patient Assistance Program, patients who are experiencing financial difficulties may be able to receive AUVI-Q at no cost.

To be eligible for assistance, a patient must:

Patients who are eligible for Medicaid coverage may be eligible for assistance to receive AUVI-Q at no cost.

PATIENT ASSISTANCE FORM

Indication
AUVI-Q® (epinephrine injection, USP) is a prescription medicine used to treat life-threatening allergic reactions, including anaphylaxis, in people who are at risk for or have a history of serious allergic reactions.

Important Safety Information
AUVI-Q is for immediate self (or caregiver) administration and does not take the place of emergency medical care. Seek immediate medical treatment after using AUVI-Q. Each AUVI-Q contains a single dose of epinephrine. AUVI-Q should only be injected into your outer thigh, through clothing if necessary. If you inject a young child or infant with AUVI-Q, hold their leg firmly in place before and during the injection to prevent injuries. Do not inject AUVI-Q into any other part of your body, such as into veins, buttocks, fingers, toes, hands, or feet. If this occurs, seek immediate medical treatment and make sure to inform the healthcare provider of the location of the accidental injection. Only a healthcare provider should give additional doses of epinephrine if more than two doses are necessary for a single allergic emergency.

Rarely, patients who use AUVI-Q may develop infections at the injection site within a few days of an injection. Some of these infections can be serious. Call your healthcare provider right away if you have any of the following symptoms at an injection site: redness that does not go away, swelling, tenderness, or the area feels warm to the touch.

If you have certain medical conditions, or take certain medicines, your condition may get worse or you may have more or longer lasting side effects when you use AUVI-Q. Be sure to tell your healthcare provider about all the medicines you take, especially medicines for asthma. Also tell your healthcare provider about all of your medical conditions, especially if you have asthma, a history of depression, thyroid problems, Parkinson’s disease, diabetes, heart problems or high blood pressure, have any other medical conditions, are pregnant or plan to become pregnant, or are breastfeeding or plan to breastfeed. Epinephrine should be used with caution if you have heart disease or are taking certain medicines that can cause heart-related (cardiac) symptoms.

Common side effects include fast, irregular or ‘pounding’ heartbeat, sweating, shakiness, headache, paleness, feelings of over excitement, nervousness, or anxiety, weakness, dizziness, nausea and vomiting, or breathing problems. These side effects usually go away quickly, especially if you rest. Tell your healthcare provider if you have any side effect that bothers you or that does not go away.

Please see the full Prescribing Information and the Patient Information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Direct delivery service

Work with your doctor to have AUVI-Q delivered to your home:

Download the enrollment form, fill out your information, and bring it to your physician.
The AUVI-Q direct delivery service will call or text you to schedule your delivery.
Your AUVI-Q will be directly shipped to your home.
DOWNLOAD ENROLLMENT FORM